Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway

Vulvar Cancer

(2019) Daniel Weinberg et al.   OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA

IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway

(2019) Jing Chu et al.   Biomed Research International

Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing αⅤβ3 integrin/FAK/PI3K/Akt signaling activation

(2019) Yan Chen et al.   OncoTargets and Therapy

Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway

(2018) Chih-Yuan Fang et al.   ENVIRONMENTAL TOXICOLOGY

HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer

(2018) Satoshi Sugita et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis

(2018) Guo-Li Shao et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Porcine reproductive and respiratory syndrome virus inhibits MARC-145 proliferation via inducing apoptosis and G2/M arrest by activation of Chk/Cdc25C and p53/p21 pathway

(2018) Linlin Song et al.   Virology Journal

Identification of molecular targets in vulvar cancers

(2017) Marguerite L. Palisoul et al.   GYNECOLOGIC ONCOLOGY

The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation

(2017) Richard W. Birkinshaw et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest

(2017) Shun Li et al.   Oncology Letters

Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma

(2017) Sufang Yang et al.   Oncology Letters

Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway

(2017) Wei Li et al.   Cancer Medicine

Risk factors and treatment for recurrent vulvar squamous cell carcinoma

(2016) L.S. Nooij et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression

(2016) ZHIJUN PEI et al.   ONCOLOGY REPORTS

Potential Signaling Pathways Involved in the Clinical Application of Oxymatrine

(2016) Mei-Li Lu et al.   PHYTOTHERAPY RESEARCH

The MAPK pathway across different malignancies: A new perspective

(2014) Mauricio Burotto et al.   CANCER

Oxymatrine targets EGFRp-Tyr845 and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells

(2014) Bingyu Guo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma

(2014) Marjolijn D. Trietsch et al.   GYNECOLOGIC ONCOLOGY

Targeting RAS–ERK signalling in cancer: promises and challenges

(2014) Ahmed A. Samatar et al.   NATURE REVIEWS DRUG DISCOVERY

Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells

(2014) Jun Liu et al.   TUMOR BIOLOGY

KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites

(2011) K. Omholt et al.   CLINICAL CANCER RESEARCH

Expression and prognostic role of pan-Ras, Raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma

(2011) L. Chen et al.   EJSO

Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy

(2011) L S Steelman et al.   LEUKEMIA

Intracellular Signaling Pathways Regulate Hormone-Dependent Kallikrein Gene Expression

(2008) Miltiadis Paliouras et al.   TUMOR BIOLOGY